CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme
October 11, 2021 08:00 ET
|
CNS Pharmaceuticals, Inc.
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for...
Husson University Graduate Students Reopen Free Physical Therapy Clinic
October 01, 2021 08:10 ET
|
Husson University
BANGOR, MAINE, Oct. 01, 2021 (GLOBE NEWSWIRE) -- With COVID-19 vaccinations on the rise, Husson University’s College of Health and Pharmacy has decided to reopen its SOARing Eagles Healthcare clinic...
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
September 14, 2021 09:01 ET
|
Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
August 30, 2021 09:15 ET
|
Protagenic Therapeutics, Inc.
Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Protagenic...
Celsion Corporation to Hold Second Quarter 2021 Financial Results and Business Update Conference Call on Thursday, August 12, 2021
August 05, 2021 08:00 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
Ear Nose and Throat (ENT) Treatment Market Value Surpass To Reach US$ 30.2 Billion By 2028 Covering Covid-19 Analysis: Acumen Research and Consulting
August 03, 2021 10:20 ET
|
Acumen Research and Consulting
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The Global Ear, Nose, and Throat (ENT) Treatment Market is expected to grow at a CAGR of around 5.5% from 2021 to 2028 and expected to reach around US$...
Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology
July 06, 2021 09:00 ET
|
Auris Medical AG
Treatment of KRAS-driven colorectal cancer selected as first therapeutic indication for OligoPhore™ platformCompany to launch development program under project code AM-401 with aim of IND submission...
Canadians living with mental health conditions stand to save over $57 billion with use of pharmacogenetic testing
June 08, 2021 07:00 ET
|
Inagene Diagnostics Inc.
TORONTO, June 08, 2021 (GLOBE NEWSWIRE) -- Inagene Diagnostic Inc., a Canadian pharmacogenetic testing company, and Calian Group Ltd., one of Canada's largest national health services organizations,...
Dimensions Health Centres Announces Closing of First Treatment Center on Maple Lake in the Algonquin Highlands
May 25, 2021 08:30 ET
|
Dimensions Health Centres
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) -- Dimensions Health Centres (“Dimensions”), a psychedelic treatment company focused on inpatient treatment integrating neuroscience with traditional healing...
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
May 12, 2021 13:00 ET
|
Philogen
Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress May 12, 2021 NidlegyTM on track for Phase III European trial in stage IIIB/C melanoma. Opening of additional...